215 related articles for article (PubMed ID: 12543657)
1. Population pharmacokinetics of linezolid in patients treated in a compassionate-use program.
Meagher AK; Forrest A; Rayner CR; Birmingham MC; Schentag JJ
Antimicrob Agents Chemother; 2003 Feb; 47(2):548-53. PubMed ID: 12543657
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme.
Rayner CR; Forrest A; Meagher AK; Birmingham MC; Schentag JJ
Clin Pharmacokinet; 2003; 42(15):1411-23. PubMed ID: 14674791
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic evaluation of linezolid in patients with major thermal injuries].
Le Floch R; Arnould JF; Vinsonneau C; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Lovering AM
Pathol Biol (Paris); 2010 Apr; 58(2):e27-31. PubMed ID: 19854590
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intravenous and oral linezolid in adults with cystic fibrosis.
Keel RA; Schaeftlein A; Kloft C; Pope JS; Knauft RF; Muhlebach M; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2011 Jul; 55(7):3393-8. PubMed ID: 21518837
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of linezolid in septic patients with and without extended dialysis.
Swoboda S; Ober MC; Lichtenstern C; Saleh S; Schwenger V; Sonntag HG; Haefeli WE; Hempel G; Hoppe-Tichy T; Weigand MA
Eur J Clin Pharmacol; 2010 Mar; 66(3):291-8. PubMed ID: 20013257
[TBL] [Abstract][Full Text] [Related]
7. Linezolid clearance during continuous venovenous hemodiafiltration: a case report.
Kraft MD; Pasko DA; DePestel DD; Ellis JJ; Peloquin CA; Mueller BA
Pharmacotherapy; 2003 Aug; 23(8):1071-5. PubMed ID: 12921253
[TBL] [Abstract][Full Text] [Related]
8. Linezolid pharmacokinetics in an obese patient.
Mersfelder TL; Smith CL
Am J Health Syst Pharm; 2005 Mar; 62(5):464, 467. PubMed ID: 15745906
[No Abstract] [Full Text] [Related]
9. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.
Matsumoto K; Takeshita A; Ikawa K; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
Int J Antimicrob Agents; 2010 Aug; 36(2):179-81. PubMed ID: 20392606
[TBL] [Abstract][Full Text] [Related]
10. Linezolid pharmacokinetics in adult patients with cystic fibrosis.
Bosso JA; Flume PA; Gray SL
Antimicrob Agents Chemother; 2004 Jan; 48(1):281-4. PubMed ID: 14693551
[TBL] [Abstract][Full Text] [Related]
11. Age and sex effects on the pharmacokinetics of linezolid.
Sisson TL; Jungbluth GL; Hopkins NK
Eur J Clin Pharmacol; 2002 Jan; 57(11):793-7. PubMed ID: 11868801
[TBL] [Abstract][Full Text] [Related]
12. Absolute bioavailability and pharmacokinetics of linezolid in hospitalized patients given enteral feedings.
Beringer P; Nguyen M; Hoem N; Louie S; Gill M; Gurevitch M; Wong-Beringer A
Antimicrob Agents Chemother; 2005 Sep; 49(9):3676-81. PubMed ID: 16127039
[TBL] [Abstract][Full Text] [Related]
13. Impact of ontogeny on linezolid disposition in neonates and infants.
Kearns GL; Jungbluth GL; Abdel-Rahman SM; Hopkins NK; Welshman IR; Grzebyk RP; Bruss JB; Van Den Anker JN;
Clin Pharmacol Ther; 2003 Nov; 74(5):413-22. PubMed ID: 14586382
[TBL] [Abstract][Full Text] [Related]
14. [Linezolid, an agent from a new class of antibiotics].
Kuijper EJ; Schippers EF; Bernards AT
Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
[TBL] [Abstract][Full Text] [Related]
15. [Linezolid for pediatric infections].
Moulin F; Hériveaux B; Vallet C
Arch Pediatr; 2010 Jun; 17(6):762-3. PubMed ID: 20654880
[No Abstract] [Full Text] [Related]
16. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial.
Stalker DJ; Jungbluth GL
Clin Pharmacokinet; 2003; 42(13):1129-40. PubMed ID: 14531724
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries.
Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C
J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses.
Gee T; Ellis R; Marshall G; Andrews J; Ashby J; Wise R
Antimicrob Agents Chemother; 2001 Jun; 45(6):1843-6. PubMed ID: 11353635
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure.
Tsuji Y; Hiraki Y; Mizoguchi A; Hayashi W; Kamohara R; Kamimura H; Karube Y
J Infect Chemother; 2008 Apr; 14(2):156-60. PubMed ID: 18622681
[TBL] [Abstract][Full Text] [Related]
20. Single dose pharmacokinetics of linezolid in infants and children.
Kearns GL; Abdel-Rahman SM; Blumer JL; Reed MD; James LP; Jacobs RF; Bradley JA; Welshman IR; Jungbluth GL; Stalker DJ;
Pediatr Infect Dis J; 2000 Dec; 19(12):1178-84. PubMed ID: 11144380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
